Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,677 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 1-25 of 52 matching filings.

Per page
25
Current page
1
10-Q File 001-36407

MARCH 31, 2019 FORM 10-Q

Filing date
02 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
10-Q File 001-36407

Q3 2018 FORM 10-Q

Filing date
07 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
10-Q File 001-36407

Q2 2018 FORM 10-Q

Filing date
02 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .